- Home
- NRBO vs GENK Comparison
NRBO vs GENK Comparison
Compare NRBO & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRBO
- GENK
- Stock Information
- Founded
- NRBO N/A
- GENK 2011
- Country
- NRBO United States
- GENK United States
- Employees
- NRBO N/A
- GENK N/A
- Industry
- NRBO Biotechnology: Pharmaceutical Preparations
- GENK Restaurants
- Sector
- NRBO Health Care
- GENK Consumer Discretionary
- Exchange
- NRBO Nasdaq
- GENK Nasdaq
- Market Cap
- NRBO 45.4M
- GENK 44.3M
- IPO Year
- NRBO N/A
- GENK 2023
- Fundamental
- Price
- NRBO $3.50
- GENK $8.01
- Analyst Decision
- NRBO Strong Buy
- GENK Strong Buy
- Analyst Count
- NRBO 1
- GENK 3
- Target Price
- NRBO $10.00
- GENK $13.17
- AVG Volume (30 Days)
- NRBO 25.6K
- GENK 40.4K
- Earning Date
- NRBO 08-14-2024
- GENK 07-31-2024
- Dividend Yield
- NRBO N/A
- GENK N/A
- EPS Growth
- NRBO N/A
- GENK N/A
- EPS
- NRBO N/A
- GENK N/A
- Revenue
- NRBO N/A
- GENK $195,292,000.00
- Revenue This Year
- NRBO N/A
- GENK $15.09
- Revenue Next Year
- NRBO N/A
- GENK $20.04
- P/E Ratio
- NRBO N/A
- GENK N/A
- Revenue Growth
- NRBO N/A
- GENK 12.49
- 52 Week Low
- NRBO $2.90
- GENK $5.61
- 52 Week High
- NRBO $6.75
- GENK $15.36
- Technical
- Relative Strength Index (RSI)
- NRBO 43.09
- GENK 38.38
- Support Level
- NRBO $3.22
- GENK $8.41
- Resistance Level
- NRBO $3.74
- GENK $10.09
- Average True Range (ATR)
- NRBO 0.28
- GENK 0.67
- MACD
- NRBO 0.01
- GENK -0.10
- Stochastic Oscillator
- NRBO 38.36
- GENK 13.50
About NRBO NeuroBo Pharmaceuticals Inc.
NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc is an Asian casual dining restaurant in the United States. It offers an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables.